Clinical Trial Update: Epiceram™ Device Versus Mid-Strength Topical Steroid (Fluticasone Propionate 0.05%) for Treatment of Atopic Dermatitis [Phase 4]

View source ↗

Summary

Phase 4 trial comparing the Epiceram device with Fluticasone Propionate 0.05% for Atopic Dermatitis has completed. The study was sponsored by Ceragenix Pharmace…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• EpiCeram
• Fluticasone Propionate 0.05% (Fluticasone Propionate)

Snippet

Sponsor: Ceragenix Pharmaceuticals | Conditions: Atopic Dermatitis | Phase 4 | Status: COMPLETED